ExodusPoint Capital Management’s Zynerba Pharmaceuticals, Inc ZYNE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-34,141
| Closed | -$18K | – | 2121 |
|
|
2022
Q4 | $18K | Buy |
34,141
+19,588
| +135% | +$10.3K | ﹤0.01% | 1514 |
|
|
2022
Q3 | $11K | Sell |
14,553
-3,376
| -19% | -$2.55K | ﹤0.01% | 1782 |
|
|
2022
Q2 | $20K | Sell |
17,929
-6,796
| -27% | -$7.58K | ﹤0.01% | 1801 |
|
|
2022
Q1 | $51K | Sell |
24,725
-22,934
| -48% | -$47.3K | ﹤0.01% | 1999 |
|
|
2021
Q4 | $137K | Buy |
47,659
+24,193
| +103% | +$69.5K | ﹤0.01% | 1858 |
|
|
2021
Q3 | $99K | Sell |
23,466
-20,681
| -47% | -$87.3K | ﹤0.01% | 1853 |
|
|
2021
Q2 | $234K | Buy |
44,147
+26,100
| +145% | +$138K | ﹤0.01% | 1821 |
|
|
2021
Q1 | $84K | Buy |
+18,047
| New | +$84K | ﹤0.01% | 1946 |
|
|
2020
Q3 | – | Sell |
-165,731
| Closed | -$559K | – | 2283 |
|
|
2020
Q2 | $559K | Buy |
+165,731
| New | +$559K | 0.01% | 1002 |
|
|
2020
Q1 | – | Sell |
-13,290
| Closed | -$80K | – | 1717 |
|
|
2019
Q4 | $80K | Buy |
+13,290
| New | +$80K | ﹤0.01% | 1389 |
|